Your browser doesn't support javascript.
loading
An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.
Chen, Xiao-Wu; He, Zhi-Xu; Zhou, Zhi-Wei; Yang, Tianxin; Zhang, Xueji; Yang, Yin-Xue; Duan, Wei; Zhou, Shu-Feng.
Afiliação
  • Chen XW; Department of General Surgery, The First People's Hospital of Shunde, Southern Medical University, Shunde, Foshan, Guangdong, China.
  • He ZX; Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Center & Sino-US Joint Laboratory for Medical Sciences, Guiyang Medical University, Guiyang, Guizhou, China.
  • Zhou ZW; Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA.
  • Yang T; Department of Internal Medicine, University of Utah and Salt Lake Veterans Affairs Medical Center, Salt Lake City, UT, USA.
  • Zhang X; Research Center for Bioengineering and Sensing Technology, University of Science and Technology Beijing, Beijing, China.
  • Yang YX; Department of Colorectal Surgery, General Hospital of Ningxia Medical University, Yinchuan, Ningxia, China.
  • Duan W; School of Medicine, Deakin University, Waurn Ponds, Vic., Australia.
  • Zhou SF; Guizhou Provincial Key Laboratory for Regenerative Medicine, Stem Cell and Tissue Engineering Research Center & Sino-US Joint Laboratory for Medical Sciences, Guiyang Medical University, Guiyang, Guizhou, China.
Clin Exp Pharmacol Physiol ; 42(12): 1225-38, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26218204

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Uracila / Dipeptidil Peptidase 4 / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Limite: Animals / Humans Idioma: En Revista: Clin Exp Pharmacol Physiol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Piperidinas / Uracila / Dipeptidil Peptidase 4 / Diabetes Mellitus Tipo 2 / Inibidores da Dipeptidil Peptidase IV Limite: Animals / Humans Idioma: En Revista: Clin Exp Pharmacol Physiol Ano de publicação: 2015 Tipo de documento: Article País de afiliação: China